NCT02976246View on ClinicalTrials.gov

Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

June 26, 2020

Conditions
Vitamin K SupplementationEndstage Renal DiseaseCardiovascular DiseaseBone Disease
Interventions
DIETARY_SUPPLEMENT

Vitamin K2 (MK7)

One tablet of vitamin K2 (MK7) 360 micrograms given once daily.

OTHER

Placebo

One tablet of placebo given once daily.

Trial Locations (1)

4000

Zealand University Hospital, Roskilde

All Listed Sponsors
lead

Zealand University Hospital

OTHER

NCT02976246 - Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients | Biotech Hunter | Biotech Hunter